COMP <GO>
MNKD vs MRK // ALTMAN Z-SCORE & DEBT/EQUITY
MannKind Corporation (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: MNKD 4
— MRK 7
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: MRK
LAST: $3.50 (0.00%) • MKT CAP: $1.13B
balance-sheet
0.20
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
balance-sheet
5.19
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MNKD VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MNKD | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 92.30% | 74.80% | +17.50 | MNKD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 54.50% | 20.70% | +33.80 | MNKD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 24.6x | 15.3x | +9.30 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 1.22% | 3.42% | -2.20 | MRK | /fcf-yield <GO> |
| Operating Margin | 11.10% | 34.30% | -23.20 | MRK | /operating-margins <GO> |
| Net Profit Margin | 1.70% | 28.10% | -26.40 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 22.20% | 1.30% | +20.90 | MNKD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 0.20 | 5.19 | -4.99 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.6 | 51.7 | +3.90 | MNKD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.13B | $361.02B | -$359.90B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MNKD REV | MRK REV | MNKD GROSS % | MRK GROSS % | MNKD FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $349.0M | $65.01B | 92.3% | 74.8% | $13.7M | $12.36B |
| FY 2024 | $285.5M | $64.17B | 93.9% | 76.3% | $32.8M | $18.10B |
| FY 2023 | $199.0M | $60.12B | — | — | $34.1M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MNKD // BETA —
MRK // BETA 0.92